Companies / Cardiff Oncology, Inc.
Cardiff Oncology, Inc.
Nasdaq: CRDFCIK 1213037SAN DIEGO, CA
Financials · FY2025
Ownership
77.8M shares outstanding · as of Aug 6, 2026
Ownership
| Insiders | 1.78% | 1,381,079 |
| Institutions | 29.29% | 22,788,479 |
| Public float | 68.93% | 53,625,691 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
Pace Gary WDirector | 1.74% | 1,356,376 |
Mohindru ManiCEOChief Executive Officer · Director | 0.03% | 24,703 |
Aggarwal AjayChief Operating Officer | — | — |
Armitage James ODirector | — | — |
Lindsay Brigitte UteChief Accounting Officer | — | — |
Markin Rodney SDirector | — | — |
Muntner Joshua BChief Financial Officer | — | — |
Smeal TodChief Scientific Officer | — | — |
Tannenbaum Renee PDirector | — | — |
White LaleDirector | — | — |
Institutional holders 116
View all →| Holder | Value | % of shares |
|---|---|---|
| $10.46M | 4.78% | |
| $6.78M | 3.10% | |
| $5.51M | 2.52% | |
| $5.48M | 2.51% | |
| $4.29M | 3.40% | |
| $3.39M | 1.55% | |
| $2.59M | 2.06% | |
| $1.30M | 0.59% | |
| $1.26M | 1.25% | |
| $1.08M | 0.49% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Pace Gary W Director | Buy | Common Stock | $36.6K | +30K +2.26% | 1,356,376 1.74% of shares | low |
| Jun 18, 2026 | Mohindru Mani CEO | Buy | Common Stock | $29.9K | +25K | 24,703 0.03% of shares | low |
| Jun 11, 2026 | White Lale Director | Grant | Stock Options | — | +41K +25.56% | 199,246 0.26% of shares | low |
| Jun 11, 2026 | Tannenbaum Renee P Director | Grant | Stock Options | — | +41K +24.04% | 209,331 0.27% of shares | low |
| Jun 11, 2026 | Markin Rodney S Director | Grant | Stock Options | — | +41K +18.20% | 263,430 0.34% of shares | low |
| Jun 11, 2026 | Armitage James O Director | Grant | Stock Options | — | +41K +21.63% | 228,104 0.29% of shares | low |
| Apr 27, 2026 | Aggarwal Ajay Executive | Grant | Stock Options | — | +400K | 400,000 0.51% of shares | low |
| Apr 14, 2026 | Smeal Tod Executive | Grant | Stock Options | — | +300K +30.62% | 1,279,805 1.65% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CRDF | — | 14147L108 |